Pacira BioSciences Inc (PCRX)
26.33
+0.83
(+3.25%)
USD |
NASDAQ |
Apr 26, 16:00
26.35
+0.02
(+0.08%)
After-Hours: 20:00
Pacira BioSciences Price: 26.33 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 25.34 | 26.37 | 25.33 | 26.33 | 304285.0 |
Apr 25, 2024 | 25.70 | 26.00 | 25.33 | 25.50 | 305838.0 |
Apr 24, 2024 | 26.65 | 26.77 | 25.78 | 25.90 | 359410.0 |
Apr 23, 2024 | 26.24 | 27.09 | 26.19 | 26.81 | 497169.0 |
Apr 22, 2024 | 26.19 | 26.67 | 25.74 | 26.10 | 375229.0 |
Apr 19, 2024 | 25.98 | 26.34 | 25.91 | 26.25 | 448972.0 |
Apr 18, 2024 | 26.79 | 26.84 | 26.08 | 26.10 | 622151.0 |
Apr 17, 2024 | 27.02 | 27.14 | 26.36 | 26.77 | 415509.0 |
Apr 16, 2024 | 26.43 | 27.63 | 26.29 | 26.87 | 721374.0 |
Apr 15, 2024 | 26.89 | 27.04 | 25.76 | 26.53 | 604436.0 |
Apr 12, 2024 | 27.29 | 27.29 | 26.61 | 26.83 | 471623.0 |
Apr 11, 2024 | 28.09 | 28.09 | 27.22 | 27.36 | 323567.0 |
Apr 10, 2024 | 27.89 | 28.38 | 27.52 | 27.83 | 444858.0 |
Apr 09, 2024 | 28.60 | 28.84 | 27.98 | 28.52 | 363924.0 |
Apr 08, 2024 | 28.10 | 28.73 | 28.10 | 28.48 | 326414.0 |
Apr 05, 2024 | 28.37 | 28.45 | 27.94 | 28.16 | 415395.0 |
Apr 04, 2024 | 29.05 | 29.47 | 28.18 | 28.40 | 403193.0 |
Apr 03, 2024 | 28.33 | 29.12 | 28.26 | 29.01 | 307484.0 |
Apr 02, 2024 | 28.80 | 29.17 | 28.31 | 28.51 | 477032.0 |
Apr 01, 2024 | 29.44 | 29.44 | 28.42 | 29.15 | 335797.0 |
Mar 28, 2024 | 29.15 | 29.58 | 28.86 | 29.22 | 569631.0 |
Mar 27, 2024 | 28.73 | 29.30 | 28.36 | 29.04 | 556686.0 |
Mar 26, 2024 | 29.48 | 29.48 | 28.25 | 28.51 | 531750.0 |
Mar 25, 2024 | 28.87 | 29.40 | 28.60 | 29.23 | 383011.0 |
Mar 22, 2024 | 29.37 | 29.45 | 28.44 | 28.67 | 360010.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.50
Minimum
Apr 25 2024
81.64
Maximum
Apr 08 2022
49.11
Average
47.23
Median
Dec 01 2022
Price Benchmarks
Dynavax Technologies Corp | 11.21 |
Arbutus Biopharma Corp | 2.73 |
Chimerix Inc | 0.8999 |
Karyopharm Therapeutics Inc | 1.06 |
FibroGen Inc | 1.04 |
Price Related Metrics
PE Ratio | 31.72 |
PS Ratio | 2.135 |
PEG Ratio | 0.1891 |
Price to Book Value | 1.407 |
Price to Free Cash Flow | 10.33 |
Earnings Yield | 3.15% |
Market Cap | 1.224B |
PEGY Ratio | 0.1891 |
Operating PE Ratio | 16.51 |
Normalized PE Ratio | 23.28 |